- CA$15.81m
- CA$108.27m
- CNY334.24m
- 45
- 99
- 25
- 57
2018 December 31st | 2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 401 | 438 | 340 | 355 | 334 |
Cost of Revenue | |||||
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 331 | 364 | 272 | 314 | 292 |
Operating Profit | 69.7 | 73.8 | 68.5 | 41.5 | 41.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 60.9 | 69.9 | 69 | 37.4 | 20.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 35.7 | 47.2 | 52.7 | 21.7 | 4.03 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 57.6 | 47 | 48.6 | 21.7 | 17 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 57.6 | 47 | 48.6 | 21.7 | 17 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.616 | 0.727 | 0.79 | 0.334 | 0.241 |
Dividends per Share | |||||
Special Dividends per Share |